Ashish Life Science, an export focussed, veterinary pharmaceuticals company has raised INR 45 crores in Series A funding. Eight Roads Ventures India led the round with participation from Netherlands-based, food and agriculture-focussed specialist fund, Anterra Capital.  The Company will use this first round of external capital to scale the business in its current geographies and expand into regulated markets.